Delivery Order SPE2DB22D3301-SPE2DB24FZ1AH

Award Date 7/19/24
Potential Completion Date 8/9/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 200 unit vials. The firm-fixed-price contract has a ceiling value of $3,145.50 and an ultimate completion date of November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,747,877 units of XEOMIN 100 unit vials. The $1,310.60 contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also received a separate indefinite delivery contract (IDC) from DLA valued at up to $999,999,999.00...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,317,580 units of the drug XEOMIN (200 unit vials). The contract has a Ceiling Value of $44,037.00 and an Ultimate Completion Date of May 8, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a $9,174.30 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XEOMIN 200 unit vials, a pharmaceutical product, with a completion date of August 8, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,539,303 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has a completion date of February 26, 2024, and a potential value of $1,048.48. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
This contract award is for the delivery of 4,566,711,466 units of the pharmaceutical drug XEOMIN (200 unit vials) to the Defense Logistics Agency (DLA). The $10,847.20 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of January 6, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves...
This is a $78,637.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,703,883 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a period of performance through September 25, 2024. This delivery order contract is placed against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a $12,582.00 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,446,690 units of the drug XEOMIN in 200-unit vials. The contract does not have a set-aside designation and has an ultimate completion date of September 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $18,873.00, is for the delivery of 4,566,181,768 units of XEOMIN 200 unit vials. The contract has a Firm Fixed Price pricing type and a period of performance through November 13, 2024. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,562,593 units of XEOMIN 100 unit vials. The contract has a potential value of $13,106.00 and a completion date of February 26, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ1AH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,214,300 units of the drug XEOMIN in 200-unit vials. The contract, valued at $10,485.00, has a firm fixed price and a completion date of August 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 10/18/24, 9:20 AM